Taiga Ichinomiya

Prof. Taiga Ichinomiya

Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Critical Care
Verified
Journal Article
Closed access
MSMotohiro Sekino
Motohiro Sekino
HFHiroyuki Funaoka
Hiroyuki Funaoka
SSShuntaro Sato
Shuntaro Sato
KOKyoko Okada
Kyoko Okada
HIHaruka Inoue
Haruka Inoue
THTetsuya Hara
Tetsuya Hara

22 January 2019 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
KHKumiko Hida
Kumiko Hida
HMHiroaki Murata
Hiroaki Murata
TITaiga Ichinomiya
Taiga Ichinomiya
HIHaruka Inoue
Haruka Inoue
SSShuntaro Sato
Shuntaro Sato
THTetsuya Hara
Tetsuya Hara
Background and objectives This randomized, controlled, double-blind trial compared the effectiveness of levobupivacaine delivery of a programmed intermittent paravertebral bolus with a continuous paravertebral infusion. Methods Thirty-two consecutively enrolled patients who underwent unilateral video-assisted thoracic surgery were randomized to receive either a programmed intermittent paravertebral bolus of 10 mL of 0.2% levobupivacaine every 2 hours (Bolus group, n=16) or a continuous paravertebral infusion of 0.2% levobupivacaine at 5 mL/hour (Infusion group, n=16) after the operation. Postoperatively, after injection of 20 mL of 0.25% levobupivacaine through the paravertebral catheter, a mechanical infusion pump was set depending on the assigned group. The primary efficacy outcome was the number of anesthetized dermatomes 24 hours after the initial bolus of levobupivacaine. The secondary efficacy outcomes included the number of anesthetized dermatomes at other time points, pain at rest and coughing, additional analgesic use and patient acceptance of the analgesic technique. Arterial levobupivacaine concentration was measured to ensure safety. P<0.05 was considered statistically significant. Results The mean (95% CI) number of anesthetized dermatomes 24 hours after the initial bolus of levobupivacaine was significantly larger among subjects receiving programmed intermittent bolus (n=16) compared with those receiving continuous infusion (n=16; 6.8 (5.7–7.9) vs 3.1 (2.0–4.2); p<0.001). The arterial levobupivacaine concentration did not reach a toxic level. Conclusions The programmed intermittent paravertebral bolus of levobupivacaine provided a wider dermatomal spread of sensory block than continuous paravertebral infusion with an identical hourly dose of levobupivacaine. Trial registration number UMIN000022532.

20 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
SWShanshan Wang
Shanshan Wang
TITaiga Ichinomiya
Taiga Ichinomiya
YTYuki Terada
Yuki Terada
DWDongsheng Wang
Dongsheng Wang
Hemal PatelHemal Patel
Hemal Patel
BHBrian Head
Brian Head
Mitochondrial dysfunction plays a pivotal role in the Alzheimer’s Disease (AD) pathology. Disrupted mitochondrial dynamics (i.e., fusion/fission balance), which are essential for normal mitochondria structure and function, are documented in AD. Caveolin-1 (Cav-1), a membrane/lipid raft (MLR) scaffolding protein regulates metabolic pathways in several different cell types such as hepatocytes and cancer cells. Previously, we have shown decreased expression of Cav-1 in the hippocampus of 9-month (m) old PSAPP mice, while hippocampal overexpression of neuron-targeted Cav-1 using the synapsin promoter (i.e., SynCav1) preserved cognitive function, neuronal morphology, and synaptic ultrastructure in 9 and 12 m PSAPP mice. Considering the central role of energy production in maintaining normal neuronal and synaptic function and survival, the present study reveals that PSAPP mice exhibit disrupted mitochondrial distribution, morphometry, and respiration. In contrast, SynCav1 mitigates mitochondrial damage and loss and enhances mitochondrial respiration. Furthermore, by examining mitochondrial dynamics, we found that PSAPP mice showed a significant increase in the phosphorylation of mitochondrial dynamin-related GTPase protein (DRP1), resulting in excessive mitochondria fragmentation and dysfunction. In contrast, hippocampal delivery of SynCav1 significantly decreased p-DRP1 and augmented the level of the mitochondrial fusion protein, mitofusin1 (Mfn1) in PSAPP mice, a molecular event, which may mechanistically explain for the preserved balance of mitochondria fission/fusion and metabolic resilience in 12 m PSAPP-SynCav1 mice. Our data demonstrate the critical role for Cav-1 in maintaining normal mitochondrial morphology and function through affecting mitochondrial dynamics and explain a molecular and cellular mechanism underlying the previously reported neuroprotective and cognitive preservation induced by SynCav1 in PSAPP mouse model of AD.

10 June 2010 in Anaesthesia
Verified
Journal Article
Open access
PDF file
UHU. Higashijima
U. Higashijima
YTY. Terao
Y. Terao
TITaiga Ichinomiya
Taiga Ichinomiya
KMK. Miura
K. Miura
MFM. Fukusaki
M. Fukusaki
KSK. Sumikawa
K. Sumikawa
Summary: The aim of this study was to determine the effect of thiamylal and propofol on heart rate‐corrected QT (QTc) interval during anaesthetic induction. We studied 50 patients undergoing lumbar spine surgery. Patients were administered 3 μg.kg −1 fentanyl and were randomly allocated to receive 5 mg.kg −1 thiamylal or 1.5 mg.kg −1 propofol as an induction agent. Tracheal intubation was performed after vecuronium administration. Heart rate, mean arterial pressure, bispectral index score, and 12‐lead electrocardiogram were recorded at the following time points: just before (T1) and 2 min after (T2) fentanyl administration; 2 min after anaesthetic administration (T3); 2.5 min after vecuronium injection (T4); and 2 min after intubation (T5). Thiamylal prolonged (p < 0.0001), but propofol shortened (p < 0.0001), the QTc interval.

3 May 2019 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
SSSaki Shiraishi
Saki Shiraishi
SCSungsam Cho
Sungsam Cho
DADaiji Akiyama
Daiji Akiyama
TITaiga Ichinomiya
Taiga Ichinomiya
ISItsuko Shibata
Itsuko Shibata
THTetsuya Hara
Tetsuya Hara

1 August 2019 in Current Opinion in Anaesthesiology
Verified
Journal Article
Closed access
HMHiroaki Murata
Hiroaki Murata
TITaiga Ichinomiya
Taiga Ichinomiya
THTetsuya Hara
Tetsuya Hara
Peroral endoscopic myotomy (POEM) was developed in Japan as a less invasive treatment for esophageal achalasia requiring general anesthesia under positive pressure ventilation. In 2018, the Japan Gastroenterological Endoscopy Society published the first guidelines describing the standard care for POEM. Based on these guidelines, we discuss the typical approach to anesthesia during POEM for the management of esophageal achalasia in Japan. Prior cleansing of the esophagus is essential to prevent both aspiration during induction of anesthesia and contamination of the mediastinum and thoracic/abdominal cavity by esophageal remnants after endoscopic resection of the esophageal mucosa. Although rare, adverse events related to intraoperative carbon dioxide insufflation occur. These are treated through percutaneous needle decompression and insertion of a chest drainage tube for pneumoperitoneum and pneumothorax, respectively. Caution should be exercised regarding the development of subcutaneous emphysema and its involvement in airway obstruction. Prevention of aspiration pneumonia and adverse events related to the insufflation of carbon dioxide is essential in the management of esophageal achalasia through POEM. Close cooperation between gastrointestinal endoscopic surgeons and anesthesiologists is indispensable in POEM.